SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 585.60 millions for the March 2025 quarter. The mentioned figure indicates a growth of about 34.66% as compared to Rs. 434.86 millions during the year-ago period.Profit for the quarter ended March 2025 rises by 85.49% to Rs. 65.83  millions from Rs. 35.49 millions.Operating Profit saw a handsome growth to 114.84 millions from 51.56 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 585.60 434.86 34.66 2687.16 2087.02 28.76 2687.16 2087.02 28.76
Other Income 27.70 24.87 11.38 81.90 92.79 -11.74 81.90 92.79 -11.74
PBIDT 114.84 51.56 122.73 592.61 323.46 83.21 592.61 323.46 83.21
Interest 2.59 2.17 19.35 9.58 8.14 17.69 9.58 8.14 17.69
PBDT 110.13 49.39 122.98 779.90 315.32 147.34 779.90 315.32 147.34
Depreciation 23.05 4.03 471.96 81.31 16.63 388.94 81.31 16.63 388.94
PBT 87.08 45.36 91.98 698.59 298.69 133.88 698.59 298.69 133.88
TAX 21.25 9.87 115.30 144.98 74.06 95.76 144.98 74.06 95.76
Deferred Tax 8.86 -0.17 -5311.76 9.26 -1.54 -701.30 9.26 -1.54 -701.30
PAT 65.83 35.49 85.49 553.61 224.63 146.45 553.61 224.63 146.45
Equity 132.80 132.19 0.46 132.80 132.19 0.46 132.80 132.19 0.46
PBIDTM(%) 19.61 11.86 65.40 22.05 15.50 42.29 22.05 15.50 42.29

Jagsonpal Pharma Share Price

194.55 0.10 (0.05%)
16-Apr-2026 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1699.40
Dr. Reddys Lab 1222.00
Cipla 1231.20
Zydus Lifesciences 941.55
Lupin 2318.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×